<h1>Competition approval for acquisition of minority shareholding in Intas permits investment subject to proposed modifications.</h1> The Competition Commission of India approved under Section 31(1) the acquisition by Canary Investments Limited and Link Investment Trust II of less than five percent shareholding in Intas Pharmaceuticals Limited, a vertically integrated Indian public pharmaceutical company; approval is subject to modifications proposed by the acquirers and the Commission's detailed order will follow.